148 related articles for article (PubMed ID: 22178505)
41. Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma.
Zhang AY; Lai CL; Poon RT; Huang FY; Seto WK; Fung J; Wong DK; Yuen MF
J Gastroenterol Hepatol; 2016 Sep; 31(9):1638-45. PubMed ID: 26905957
[TBL] [Abstract][Full Text] [Related]
42. Hepatitis B virus core protein variations differ in tumor and adjacent nontumor tissues from patients with hepatocellular carcinoma.
Zhu Y; Jin Y; Cai X; Bai X; Chen M; Chen T; Wang J; Qian G; Gu J; Li J; Tu H
Intervirology; 2012; 55(1):29-35. PubMed ID: 21325784
[TBL] [Abstract][Full Text] [Related]
43. [Relationship between mutation on precore region of integrated HBV DNA and p53 gene mutation in hepatocellular carcinoma].
Wang XH; Wang PL
Ai Zheng; 2003 Jul; 22(7):715-8. PubMed ID: 12866962
[TBL] [Abstract][Full Text] [Related]
44. Subcellular mislocalization of mutant hepatitis B X proteins contributes to modulation of STAT/SOCS signaling in hepatocellular carcinoma.
Bock CT; Toan NL; Koeberlein B; Song le H; Chin R; Zentgraf H; Kandolf R; Torresi J
Intervirology; 2008; 51(6):432-43. PubMed ID: 19321929
[TBL] [Abstract][Full Text] [Related]
45. Clinicopathological characteristics of PIK3CA and HBx mutations in Korean patients with hepatocellular carcinomas.
Kim DC; Chung WJ; Lee JH; Jang BK; Hwang JS; Kang KJ; Kwon SY
APMIS; 2014 Oct; 122(10):1001-6. PubMed ID: 24673525
[TBL] [Abstract][Full Text] [Related]
46. TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia.
Gouas DA; Villar S; Ortiz-Cuaran S; Legros P; Ferro G; Kirk GD; Lesi OA; Mendy M; Bah E; Friesen MD; Groopman J; Chemin I; Hainaut P
Carcinogenesis; 2012 Jun; 33(6):1219-24. PubMed ID: 22759751
[TBL] [Abstract][Full Text] [Related]
47. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
48. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
49. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma.
Wong DK; Yuen MF; Poon RT; Yuen JC; Fung J; Lai CL
J Hepatol; 2006 Oct; 45(4):553-9. PubMed ID: 16904225
[TBL] [Abstract][Full Text] [Related]
50. Effects of hepatitis B virus X protein on the development of liver cancer.
Zhang X; Zhang H; Ye L
J Lab Clin Med; 2006 Feb; 147(2):58-66. PubMed ID: 16459163
[TBL] [Abstract][Full Text] [Related]
51. [X protein variations of genotype B and C hepatitis B virus isolated from the patients with hepatocellular carcinoma].
Xu X; Chen WN; Zheng DL; Huang QL; Lin X
Ai Zheng; 2004 Jul; 23(7):756-61. PubMed ID: 15248907
[TBL] [Abstract][Full Text] [Related]
52. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
[TBL] [Abstract][Full Text] [Related]
53. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma.
Muroyama R; Kato N; Yoshida H; Otsuka M; Moriyama M; Wang Y; Shao RX; Dharel N; Tanaka Y; Ohta M; Tateishi R; Shiina S; Tatsukawa M; Fukai K; Imazeki F; Yokosuka O; Shiratori Y; Omata M
J Hepatol; 2006 Dec; 45(6):805-12. PubMed ID: 17050029
[TBL] [Abstract][Full Text] [Related]
54. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
[TBL] [Abstract][Full Text] [Related]
55. Identification of a natural mutant of HBV X protein truncated 27 amino acids at the COOH terminal and its effect on liver cell proliferation.
Zhang H; Shan CL; Li N; Zhang X; Zhang XZ; Xu FQ; Zhang S; Qiu LY; Ye LH; Zhang XD
Acta Pharmacol Sin; 2008 Apr; 29(4):473-80. PubMed ID: 18358094
[TBL] [Abstract][Full Text] [Related]
56. Hepatitis B virus BCP, Precore/core, X gene mutations/genotypes and the risk of hepatocellular carcinoma in India.
Asim M; Malik A; Sarma MP; Polipalli SK; Begum N; Ahmad I; Khan LA; Husain SA; Akhtar N; Husain S; Thayumanavan L; Singla R; Kar P
J Med Virol; 2010 Jul; 82(7):1115-25. PubMed ID: 20513073
[TBL] [Abstract][Full Text] [Related]
57. Identification of hepatitis B virus X gene variants between hepatocellular carcinoma tissues and pericarcinoma liver tissues in Eastern China.
Wang D; Cai H; Yu WB; Yu L
Int J Clin Exp Pathol; 2014; 7(9):5988-96. PubMed ID: 25337243
[TBL] [Abstract][Full Text] [Related]
58. C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma.
Sze KM; Chu GK; Lee JM; Ng IO
Hepatology; 2013 Jan; 57(1):131-9. PubMed ID: 22821423
[TBL] [Abstract][Full Text] [Related]
59. Overexpression of cyclin A in hepatocellular carcinoma and its relationship with HBx gene integration.
Zhang Y; Peng Z; Qiu G; Wang Z; Gu W
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):353-5. PubMed ID: 12408762
[TBL] [Abstract][Full Text] [Related]
60. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
Hann HW; Lee J; Bussard A; Liu C; Jin YR; Guha K; Clayton MM; Ardlie K; Pellini MJ; Feitelson MA
Cancer Res; 2004 Oct; 64(20):7329-35. PubMed ID: 15492253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
